Growing role of SGLT2i in heart failure: evidence from clinical trials.

Ajay VaradhanKatarina StephanRahul GuptaApurva V VyasPurva RanchalWilbert S AronowNael HawwaGregg M Lanier

Published in: Expert review of clinical pharmacology (2022)

: The promising pathophysiological profile of SGLT2i and their role in cardioprotective effects demonstrate an invaluable discovery in the management of patients with HF irrespective of their diabetes status.

Keyphrases

heart failure
clinical trial
type diabetes
acute heart failure
cardiovascular disease
small molecule
glycemic control
left ventricular
atrial fibrillation
cardiac resynchronization therapy
metabolic syndrome
adipose tissue